U.S. Physical Therapy, Inc. (USPH) SEC Filings & Earnings Calls
EquiReason read 24 U.S. Physical Therapy, Inc. SEC filings in the last 12 months. Latest: 8-K on 2026-09-28 — USPH entered into a 45-month forward-starting interest rate swap with $170.6M notional, fixing variable rate on term debt at 4.578% from Jun 30, 2027 to Apr 14, 2031..
Source: SEC EDGAR filings · figures as of 2026-06-30 · read by EquiReason
- Market cap
- 1.3B
- P/E TTM
- —
- Dividend yield
- 2.1%
- 52-week
- —
- Next earnings
- 4 Nov, in 11 days
Every filing, read
last 12 months · SECWhat happened, the numbers inside, guidance and risks. The original is one click away.
28 Sep 20268-K · 1.01, 2.03USPH entered into a 45-month forward-starting interest rate swap with $170.6M notional, fixing variable rate on term debt at 4.578% from Jun 30, 2027 to Apr 14, 2031.open
Risks flagged
Interest rate risk management; swap counterparty risk with Bank of America
“Swap counterparty is also Administrative Agent and lender under Credit Agreement”
14 Aug 20268-K · 1.01, 5.02, 8.01U.S. Physical Therapy appointed Nchacha Etta as EVP and CFO with an employment agreement including $625K base salary, equity grants, and change-in-control benefits.open
Figures in the filing · each found in the filing text
| annual base salary · FY2026 | $625000.00 | |
| initial equity grant market value · FY2026 | $550000.00 | |
| restricted stock/RSU grant market value · FY2026 | $200000.00 |
Risks flagged
New CFO appointment introduces transition risk, but compensation package suggests retention focus.
“Employment agreement with severance and change-in-control benefits.”
10 Aug 20268-K · 7.01Visits per clinic per day 33.5; Net rate $107.59 (+2% y/y); PT revenue growth 8.4open
Figures in the filing · each found in the filing text
| Visits per clinic per day · Q2-2026 | 33.5 | |
| Net rate · Q2-2026 | $107.59 | +2% y/y |
| PT revenue growth · Physical Therapy · Q2-2026 | 8.4% | |
| IIP revenue growth · Industrial Injury Prevention · Q2-2026 | 9.0% | |
| Same-store revenue growth (PT) · Physical Therapy · Q2-2026 | 3.0% | |
| Healthcare cost impact · H1-2026 | $3M |
Guidance
Management optimistic on volume growth and hospital partnerships, but acknowledges margin headwinds from healthcare costs and hiring.
Risks flagged
Self-insured healthcare costs running well above average, impacting margins.
“$3.2M above average healthcare costs in H1 2026”
Front-loaded hiring costs for hospital partnerships may pressure near-term margins.
“Approximately 50 clinicians hired in advance for NYU affiliation”
7 Aug 202610-QUSPH reported Q2 2026 net revenue of $214.1M (+8.5% YoY) and net income attributable to shareholders of $9.9M (-20.1% YoY), with gross margin declining 150 bps.earningsopen
Figures in the filing · each found in the filing text
| Net revenue · Q2-2026 | $214M | +8% y/y |
| Net income attributable to USPH shareholders · Q2-2026 | $10M | -20% y/y |
| Adjusted EBITDA · Q2-2026 | $27M | +0% y/y |
| Operating Results (non-GAAP) · Q2-2026 | $11M | -9% y/y |
| Patient visits · Physical Therapy Operations · Q2-2026 | 1,661,694 | +7% y/y |
| Physical therapy revenue per patient visit · Physical Therapy Operations · Q2-2026 | $107.59 | +2% y/y |
| Average daily visits per clinic · Physical Therapy Operations · Q2-2026 | 33.5 | +2% y/y |
| Mature revenue percent change · Physical Therapy Operations · Q2-2026 | 3.5% | |
| Number of clinics · Q2-2026 | 781 | +2% y/y |
| Physical therapy net revenue · Physical Therapy Operations · Q2-2026 | $182M | +8% y/y |
Risks flagged
Medicare Reimbursement Volatility
“For 2026, the MPFS increased Medicare reimbursement for therapy services by approximately 1.75% as compared to the reimbursement rates for 2025.” · word for word
Labor Cost Pressure
“Excluding certain incentive costs related to the Metro acquisition, salaries and related costs as a percentage of revenue increased to 57.5% for the 2026 Second Quarter from 56.4% for the 2025 Second Quarter.” · word for word
Acquisition Integration Risk
“Our strategy is to continue acquiring multi-clinic outpatient physical therapy practices” · word for word
Interest Rate Risk
“Interest expense increased by $0.8 million to $3.2 million for the 2026 Second Quarter compared to $2.4 million for the 2025 Second Quarter due to a higher average outstanding balance on our revolving credit facility” · word for word
6 Aug 20268-K · 2.02, 8.01U.S. Physical Therapy reported Q2 2026 total net revenue up 8.5% to $214.1M, net income down to $9.9M from $12.4M due to noncontrolling interest dilution, and reaffirmed full year guidance.earningsopen
Figures in the filing · each found in the filing text
| Total net revenue · Q2-2026 | $214M | +9% y/y |
| Net income attributable to USPH shareholders · Q2-2026 | $10M | -20% y/y |
| Adjusted EBITDA · Q2-2026 | $27M | +0% y/y |
| Patient visits · Physical Therapy · Q2-2026 | 1,661,694 | +7% y/y |
| Physical therapy net revenue per patient visit · Physical Therapy · Q2-2026 | $107.59 | +2% y/y |
| Clinic count · Q2-2026 | 781 |
Guidance
Reaffirmed full-year guidance; expects accelerating adjusted EBITDA improvement in H2 2026 driven by hospital integration and cost initiatives.
Risks flagged
Margin pressure from health benefit costs; integration of hospital affiliations may cause near-term disruption.
“Q2 2026 results included an unfavorable impact of company-provided health benefit costs compared to a favorable impact in Q2 2025, impacting margins by approximately 100 basis points.” · word for word
11 May 20268-K · 7.01Physical Therapy Revenue Increase 7.2; Same-Store Revenue Increase 2.5; Patient Volume Increase 6.9open
Figures in the filing · each found in the filing text
| Physical Therapy Revenue Increase · Physical Therapy · Q1-2026 | 7.2% | |
| Same-Store Revenue Increase · Physical Therapy · Q1-2026 | 2.5% | |
| Patient Volume Increase · Physical Therapy · Q1-2026 | 6.9% | |
| Visits per Clinic per Day · Physical Therapy · Q1-2026 | 31.8 | |
| Net Rate · Physical Therapy · Q1-2026 | $106.49 | +1% y/y |
Guidance
Reaffirmed previous guidance; management expressed confidence in achieving results as the year progresses despite weather-related headwinds.
Risks flagged
Weather-related disruptions caused loss of over 31,000 visits, negatively impacting margins
“We lost over 31,000 visits to weather, which impacts not just revenue, but the vast majority of our highest paid people we had to pay to sit at home during these weather events, which is a drag on margins.” · word for word
8 May 202610-QNet patient revenue $164M (+8% y/y); Total net revenue $198M (+8% y/y); Net income attributable to USPH shareholders $5M (-49% y/y)open
Figures in the filing · each found in the filing text
| Net patient revenue · Physical Therapy Operations · Q1-2026 | $164M | +8% y/y |
| Total net revenue · Q1-2026 | $198M | +8% y/y |
| Net income attributable to USPH shareholders · Q1-2026 | $5M | -49% y/y |
| Patient visits · Physical Therapy Operations · Q1-2026 | 1,543,144 | +7% y/y |
| Net rate per patient visit · Physical Therapy Operations · Q1-2026 | $106.49 | +1% y/y |
| Number of clinics (owned) · Q1-2026 | 755 | +4% y/y |
| Adjusted EBITDA · Q1-2026 | $20M | +4% y/y |
| Operating Results per share (non-GAAP) · Q1-2026 | $0.46 | -4% y/y |
Risks flagged
Medicare reimbursement volatility
“changes in Medicare rules and guidelines and reimbursement or failure of our clinics to maintain their Medicare certification and/or enrollment status” · word for word
Contingent consideration volatility
“Loss (gain) on change in fair value of contingent earn-out consideration $1,997” · word for word
6 May 20268-K · 2.02, 8.01USPH reports record Q1 revenue $198.3M (+7.9% YoY), net income $5.0M (down from $9.9M due to contingent earnout), reaffirms FY2026 adjusted EBITDA guidance $102-106M.earningsopen
Figures in the filing · each found in the filing text
| Total Net Revenue · Q1-2026 | $198M | +8% y/y |
| Net Income Attributable to USPH Shareholders · Q1-2026 | $5M | -49% y/y |
| Adjusted EBITDA · Q1-2026 | $20M | +4% y/y |
| Operating Results (non-GAAP) · Q1-2026 | $7M | -4% y/y |
| Physical Therapy Net Revenue · Physical Therapy · Q1-2026 | $168M | +7% y/y |
| Patient Visits · Physical Therapy · Q1-2026 | 1,543,144 | +7% y/y |
| Net Rate per Physical Therapy Visit · Physical Therapy · Q1-2026 | $106.49 | +1% y/y |
| Physical Therapy Margin · Physical Therapy · Q1-2026 | 15.8% | |
| IIP Revenue · IIP · Q1-2026 | $31M | +12% y/y |
| IIP Margin · IIP · Q1-2026 | 20.4% |
Guidance
FY2026 adjusted EBITDA $102.0M-$106.0M
USPH reaffirmed FY2026 adjusted EBITDA guidance of $102-106M, reflecting confidence in H2 initiatives.
Risks flagged
Net income decline due to contingent earnout fair value changes; GAAP loss per share.
“Net income attributable to USPH shareholders of $5.0 million for Q1 2026, compared to $9.9 million for Q1 2025. Loss per share of $0.12 for Q1 2026, compared to earnings per share of $0.80.”
PT margin compression due to investments.
“Physical therapy margin was 15.8% for Q1 2026 compared to 16.6% for Q1 2025.” · word for word
Corporate expense ratio increased.
“Corporate expense as a percentage of total revenue was 9.2% for Q1 2026 compared to 8.8% for Q1 2025.” · word for word
16 Apr 2026DEF 14AAnnual proxy statement disclosing executive compensation structure, board changes, and CFO resignationopen
Figures in the filing · each found in the filing text
| Adjusted EBITDA · FY2025 | $95M | +16% y/y |
| Net Income · FY2025 | $40M | +8% y/y |
| Operating Results · FY2025 | $58M | +27% y/y |
| Total Shareholder Return · FY2025 | $65.00 | -12% y/y |
| Dividends per share · FY2025 | $1.80 | +2% y/y |
Risks flagged
CFO departure creates transition risk
“Mr. Hendrickson resigned from his position Chief Financial Officer to be effective April 24, 2026.” · word for word
Key person reliance on CEO
“Mr. Reading has served as our Chief Executive Officer and a director since 2004 and as the Chairman of the Board since May 2024.” · word for word
15 Apr 20268-K · 1.01, 2.03U.S. Physical Therapy entered into a Fourth Amended and Restated Credit Agreement with Bank of America and other lenders, a refinancing/credit facility event.open
Risks flagged
Increased debt may pressure leverage ratios if acquisitions do not generate expected returns.
“Financial covenants include consolidated leverage ratio and fixed charge coverage ratio.”
3 Mar 20268-K · 7.01Net revenue 16.3; Adjusted EBITDA $13M (+16% y/y); Gross profit PT operations 21; Guidance: Two hospital partnerships expected to add at least $14M EBITDA in 2027open
Figures in the filing · each found in the filing text
| Net revenue · total · FY2025 | 16.3% | |
| Adjusted EBITDA · total · FY2025 | $13M | +16% y/y |
| Gross profit PT operations · physical therapy · FY2025 | 21.0% | |
| Gross profit injury prevention · injury prevention · FY2025 | 20.0% | |
| Operating income · total · FY2025 | 18.4% | |
| Q4 gross profit increase · total · Q4-2025 | 25.0% | |
| PT revenue growth · physical therapy · FY2025 | 16.0% | |
| Injury prevention revenue growth · injury prevention · FY2025 | 18.0% |
Guidance
Two hospital partnerships expected to add at least $14M EBITDA in 2027
Management expressed excitement for 2026, citing strong demand, margin improvement, and strategic hospital alliances.
Risks flagged
Medicare rate reductions continue to pressure margins, though company managed well in 2025.
“Results delivered in environment with continued Medicare rate reductions.”
27 Feb 202610-KNet patient revenue $650M (+16% y/y); Number of clinics 780 (+2% y/y); Managed care/commercial insurance revenue $315M (+19% y/y)open
Figures in the filing · each found in the filing text
| Net patient revenue · Physical Therapy Operations · FY2025 | $650M | +16% y/y |
| Number of clinics · 2025-12-31 | 780 | +3% y/y |
| Managed care/commercial insurance revenue · Physical Therapy Operations · FY2025 | $315M | +19% y/y |
| Medicare/Medicaid revenue · Physical Therapy Operations · FY2025 | $233M | +15% y/y |
| Workers' compensation insurance revenue · Physical Therapy Operations · FY2025 | $66M | +17% y/y |
| Other revenue · Physical Therapy Operations · FY2025 | $36M | -2% y/y |
| Market value of shares held by non-affiliates · 2025-06-30 | $737M | |
| Shares outstanding · 2026-02-23 | 15,122,562 | |
| Share repurchases · Q4-2025 | $6M |
Risks flagged
Medicare reimbursement cuts
“The MPFS for 2025 resulted in a decrease in Medicare reimbursement for therapy services by approximately 1.5% as compared to the reimbursement rates in effect for most of 2024.” · word for word
Regulatory compliance costs
“Compliance with such laws and regulations can be subject to future government review and interpretation, as well as significant regulatory action including fines, penalties, and exclusion from the Medicare program.” · word for word
Dependence on key personnel
“Our business depends on hiring, training, and retaining qualified employees; availability and cost of qualified physical therapists.” · word for word
26 Feb 20268-K · 5.02, 7.01, 8.01Net revenue from physical therapy operations $174M (+13% y/y); Adjusted EBITDA $25M (+14% y/y); Net income attributable to USPH shareholders $4M (-54% y/y)open
Figures in the filing · each found in the filing text
| Net revenue from physical therapy operations · physical therapy operations · Q4-2025 | $174M | +13% y/y |
| Adjusted EBITDA · Q4-2025 | $25M | +14% y/y |
| Net income attributable to USPH shareholders · Q4-2025 | $4M | -54% y/y |
| Total patient visits · Q4-2025 | 1,593,336 | +11% y/y |
| Net rate per patient visit · Q4-2025 | $106.49 | +2% y/y |
| Average daily patient visits per clinic · Q4-2025 | 32.7 | +4% y/y |
| Industrial injury prevention services revenue · industrial injury prevention services · Q4-2025 | $29M | +9% y/y |
| Number of owned and/or managed clinics · Q4-2025 | 780 | +3% y/y |
| Shares repurchased · Q4-2025 | 81,322 |
Risks flagged
CFO departure creates transition risk and potential loss of financial leadership continuity.
“CFO resignation announced; interim CFO appointed; search for permanent successor ongoing.”
4 Feb 20268-K · 8.01Annual revenues $7Mopen
Figures in the filing · each found in the filing text
| annual revenues · industrial injury prevention · FY2025 | $7M |
Risks flagged
Integration risk for acquired business and alliance execution.
“Acquisition and strategic alliance may involve integration challenges.”
7 Jan 20268-K · 8.01Annual revenues of acquired entity $8M; Annual visits of acquired entity 66,000open
Figures in the filing · each found in the filing text
| Annual revenues of acquired entity · unknown | $8M | |
| Annual visits of acquired entity · unknown | 66,000 |
12 Nov 20258-K · 7.01Visits per Clinic per Day 32.2; Volume Growth 18; Gross Profit Growth 30open
Figures in the filing · each found in the filing text
| Visits per Clinic per Day · Q3-2025 | 32.2 | |
| Volume Growth · Q3-2025 | 18.0% | |
| Gross Profit Growth · Q3-2025 | 30.0% | |
| Net PT Facilities Added · LTM | 84 | |
| Net Promoter Score · Q3-2025 | 90 |
Risks flagged
Medicare reimbursement risk; CMS final rule provides ~1.5% increase but complexity from geographic index changes.
“CMS produced the final rule... it’s got a little bit better than the last time we talked... about a 1.5% increase”
Inflationary pressure on staff costs; being offset by efficiency initiatives but remains a headwind.
“in the middle of an inflationary period and a period where staff is more expensive” · word for word
7 Nov 202510-QUSPH reported strong Q3 2025 results with revenue +17.3% YoY, net income +98.2% YoY, and record-high clinic utilization.earningsopen
Figures in the filing · each found in the filing text
| Net patient revenue · Physical Therapy · Q3-2025 | $164M | +18% y/y |
| Net revenue · Q3-2025 | $197M | +17% y/y |
| Net income attributable to USPH shareholders · Q3-2025 | $13M | +98% y/y |
| Patient visits · Physical Therapy · Q3-2025 | 1,554,207 | +18% y/y |
| Clinics number · Q3-2025 | 779 | |
| Adjusted EBITDA · Q3-2025 | $24M | +13% y/y |
| Operating Results per share · Q3-2025 | $0.66 | -4% y/y |
| Net rate per patient visit · Physical Therapy · Q3-2025 | $105.54 | -0% y/y |
| Average daily visits per clinic · Physical Therapy · Q3-2025 | 32.2 | +7% y/y |
| IIP net revenue · IIP · Q3-2025 | $29M | +15% y/y |
Risks flagged
Medicare reimbursement cuts
“The MPFS for 2025 decreased Medicare reimbursement for therapy services by approximately 2.9% as compared to the reimbursement rates in effect for most of 2024.” · word for word
Clinic closure costs
“Costs associated with the closure of 13 owned clinics during the 2025 Nine Months and 43 owned clinics in the 2024 Nine Months.” · word for word
Interest rate exposure
“The interest rate associated with borrowings on our credit facilities was 5.0% for the 2025 Third Quarter and 4.7% for the 2024 Third Quarter.” · word for word
6 Nov 20258-K · 2.02, 8.01Total revenue from physical therapy operations $168M (+18% y/y); Adjusted EBITDA $24M (+13% y/y); Net income attributable to USPH shareholders $13M; Guidance: Adjusted EBITDA $93M to $97M for full year 2025earningsopen
Figures in the filing · each found in the filing text
| Total revenue from physical therapy operations · Physical Therapy · Q3-2025 | $168M | +18% y/y |
| Adjusted EBITDA · Q3-2025 | $24M | +13% y/y |
| Net income attributable to USPH shareholders · Q3-2025 | $13M | |
| Total patient visits · Q3-2025 | 1,554,207 | +18% y/y |
| Net rate per patient visit · Q3-2025 | $105.54 | -0% y/y |
| Average daily patient visits per clinic · Q3-2025 | 32.2 | +7% y/y |
| Industrial injury prevention services revenue · IIP · Q3-2025 | $29M | +15% y/y |
| Number of clinics · Q3-2025 | 779 | |
| Dividend per share · Q4-2025 | $0.45 |
Guidance
Adjusted EBITDA $93M to $97M for full year 2025
Management reaffirmed full-year 2025 Adjusted EBITDA guidance range of $93.0 million to $97.0 million, reflecting confidence in continued growth.
Risks flagged
Net rate per patient visit slightly declined YoY (-0.1%), indicating potential pricing pressure.
“Net rate per patient visit for the 2025 Third Quarter was $105.54 compared to $105.65 for the 2024 Third Quarter.” · word for word
U.S. Physical Therapy, Inc. — questions
- What did U.S. Physical Therapy, Inc. file recently?
- 24 SEC filings in the last 12 months. Latest: 8-K on 2026-09-28 — USPH entered into a 45-month forward-starting interest rate swap with $170.6M notional, fixing variable rate on term debt at 4.578% from Jun 30, 2027 to Apr 14, 2031.
Every figure on this page comes from U.S. Physical Therapy, Inc.'s own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.
How these figures are read: methodology · EquiReason.